Dendritic Cell Vaccine for Relapsed Neuroblastoma Patient Induces Complete Remission
Cancer treatment vaccine research leads to remission in a child with a relapsed neuroblastoma.
Genetic Landscape of Common Brain Tumors Holds Key to Personalized Treatment
Researchers discover the genetic landscape of the most common form of brain tumor can be explained by abnormalities in five genes. The finding could help to develop personalized medical therapies and treatment options.
Researchers Identify Enzyme Involved in Deadly Brain Tumors
In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and glioblastoma multiforme tumors.
Aggressive Brain Tumors Can Originate from a Range of Nervous System Cells
Scientists have long believed that glioblastoma multiforme, the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. Researchers found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.
‘Fingerprinting’ Breakthrough Offers Improved Brain Tumor Diagnosis
Researchers have shown that infrared and Raman spectroscopy – coupled with statistical analysis – can be used to tell the difference between normal brain tissue and the different tumor types that may arise in this tissue, based on its individual biochemical-cell ‘fingerprint’.
